Pricing

Log inSign up

Alimera Sciences

1 follower

‌

Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Industries

Education, Pharmaceutical

Headquarters

Alpharetta, United States

Employees

51-200

Links

Org chart

Russell Skibsted
CFO & SVP
David Dyer
Chief Retina Specialist
Steve Gill
Vice President, Thought Leader Engagement At Alimera Sciences
Christopher Visick
Vice President, General Counsel
Laura Cegala Sphr, Gphr
Vice President, Human Capital
Brittany Underhill
Associate Director, Financial Reporting
LK
Larry Karner
Vice President, Managed Markets
Mike Padilla
Vice President Of Global Marketing/head Of Commercial Excellence
RS
Riz Siddiqi
Medical Director, UK & Eire
SM
Steve Morris
Vice President , Medical Director Uk, Head Of Medical Affairs Europe
Trey Kincaid
Senior Director, Finance & Corporate Controller
Bill Garner
Executive Director Marketing
Diane Reeves
Business Manager
SD
Sergei Donskihh
European IT Manager
BF
Ben Flagler
Regional Sales Director
Bryce Werner
Regional Sales Director
Tom Sinnamon
Region Director Of Sales
Catherine Griffiths
Market Access Manager, UK & Ireland
Deirdre O Reilly
Associate Director Corporate Compliance Training
David Gregory
Business Analytics Manager, EMEA
Kotaro Sai
Business Analytics Manager
Kapil Kumar
Clinical Account Specialist & Field Sales Trainer

Teams

+5

Sales and Marketing

8 members

AC
+8

Medical Affairs

11 members

Leadership Team

1 members

Clinical Operations and Research

1 members

Similar companies

SmithRx

4 followers

Bravado

6 followers

Providence Medical Technology

1 follower

Goalbook

1 follower

VentureWell

1 follower

Rethink Ed

1 follower

Nutrafol

6 followers

Bristol-Myers Squibb

175 followers

Walgreens Boots Alliance

105 followers

Guild

33 followers

Syneos Health

17 followers

Explore companies